Inotersen Subcutaneous and Sandostatin LAR Depot
Determining the interaction of Inotersen Subcutaneous and Sandostatin LAR Depot and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotersen
Brand name: Tegsedi
Synonyms: Inotersen
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: Sandostatin LAR Depot (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotersen Subcutaneous-Sandostatin LAR Depot injection
- Inotersen Subcutaneous-Sani-Supp
- Inotersen Subcutaneous-Sani-Supp rectal
- Inotersen Subcutaneous-Sansert
- Inotersen Subcutaneous-Santyl
- Inotersen Subcutaneous-Saphris
- Sandostatin LAR Depot-Inotuzumab ozogamicin
- Sandostatin LAR Depot-Inotuzumab ozogamicin Intravenous
- Sandostatin LAR Depot-Inova
- Sandostatin LAR Depot-Inova 4/1 topical
- Sandostatin LAR Depot-Inova 8/2 topical
- Sandostatin LAR Depot-Inova ACT